Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
The State Street SPDR S&P Pharmaceuticals ETF (XPH) made its debut on 06/19/2006, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)?
Launched on June 19, 2006, the State Street SPDR S&P Pharmaceuticals ETF (XPH) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Pharma segment of the equity market.
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
The State Street SPDR S&P Pharmaceuticals ETF (XPH) made its debut on 06/19/2006, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)?
The State Street SPDR S&P Pharmaceuticals ETF (XPH) was launched on June 19, 2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Pharma segment of the equity market.
US and China clash over fentanyl and tariffs at global drugs meeting
The United States and China traded barbs at a U.N. drugs meeting on Monday, with Washington accusing Beijing of failing to stop sales of precursor chemicals for fentanyl and China dismissing the allegation as false while calling the U.S. irresponsible.
XPH's 29% Run Looks Tempting, But The 5y Chart Is A Warning
SPDR S&P Pharmaceuticals ETF ( NYSEARCA:XPH ) exists to solve a specific problem: how do you gain broad exposure to pharmaceutical companies without the concentration risk of the largest healthcare names dominating your returns?
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
Designed to provide broad exposure to the Health Care ETFs category of the market, the State Street SPDR S&P Pharmaceuticals ETF (XPH) is a smart beta exchange traded fund launched on 06/19/2006.
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)?
The State Street SPDR S&P Pharmaceuticals ETF (XPH) was launched on June 19, 2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Pharma segment of the equity market.
XPH: Healthcare Dashboard For January
Healthcare providers have a good value score, and the pharmaceuticals & biotechnology subsector has a good quality score. State Street SPDR S&P Pharmaceuticals ETF provides modified equal-weighted exposure to the pharmaceutical industry, reducing company-specific risk versus cap-weighted peers. XPH is best suited for tactical allocation or swing trading, not as a long-term core holding, given its historical underperformance.
Pharma ETF (XPH) Hits a New 52-Week High
For investors seeking momentum, State Street SPDR S&P Pharmaceuticals ETF XPH is probably on the radar. The fund just hit a 52-week high and rose 61.4% from its 52-week low price of $35.22/share.
US and UK agree zero-tariffs on pharmaceuticals
The US has agreed to spare the UK from threatened trade tariffs on pharmaceutical products.
US, UK to agree to zero tariffs on pharmaceuticals, announcement expected, sources say
Britain and the United States are poised to agree to zero tariffs on pharmaceutical products, with an announcement due at the White House on Monday, according to two sources familiar with the matter.
